Navigation Links
New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension

/p>

4. Patients treated for 8 weeks with a combination of the maximum dose 300mg of SPP100 and the maximum dose 320mg of Diovan [6] (ARB[7]) showed significant clinically relevant additional BP reductions of 4.2/3.2 mmHg and 4.4/2.5 mmHg compared to SPP100 and Diovan monotherapies respectively. This large study of 1,776 patients has produced a novel observation about the benefits of combining the maximum therapeutic doses of SPP100 and Diovan. There has only been one other small study combining the maximum recommended doses of an ACE-I and an ARB which also showed significant additional reductions in BP (Poster P - 418).

5. Patients treated with a combination of the maximum dose 300mg of SPP100 and the maximum dose 320mg of Diovan (ARB) showed significantly greater reductions in BP over an entire 24-hour period compared to SPP100 and Diovan monotherapies. This is particularly important during the night-time and early morning hours as many cardiovascular events occur between 2am and 6am. The results were consistent for both patients whose blood pressure naturally decreases at night (dippers) and for those whose blood pressure remains high at night (non-dippers) (Poster P - 452).

6. In a study of obese patients, who did not achieve BP control with the diuretic HCTZ alone, it was shown that patients treated for 8 weeks with a combination of SPP100 and HCTZ provided additional significant BP reductions. The combination also improved the number of patients achieving BP control compared to those receiving HCTZ alone. The combination of SPP100 and HCTZ also did not show the increased levels of fluid retention associated with the combination of amlodipine (CCB) and HCTZ (Poster P - 401)

The World Health Organization and the JNC-VII[8] estimate that 70% of hypertensive patients currently do not reach their blood pressure goals. As many patients with hypertension require more than one antihypertensive drug to control their elevated blood pressure, it i
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
2. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
3. Expert Opinion Highlights Avigens AV411 as Potential New Therapeutic for Neuropathic Pain and Opioid Withdrawal
4. Positive Clinical Results for DG041 Lead Product Development Highlights at deCODE R&D Event
5. Ambrilia Highlights Encouraging Data for its HIV Integrase Inhibitor Program and Recent Developments at Annual Meeting
6. July Issue of Journal of Antimicrobial Chemotherapy Highlights Study of Factive Tablets for Five-Day Treatment of Community-Acquired Pneumonia
7. Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with Electroporation DNA Delivery Technology and New Devices at Gene Therapy Meeting
8. Presentations at 2007 European Stroke Congress Highlights New Direction for Viprinex (ancrod)
9. Data to be Presented at ASCO 2007 Highlights sanofi-aventis Commitment to Cancer Care and Research
10. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
11. New Critical Path Report Highlights Research Needed to Foster Generic Drug Development

Post Your Comments:
(Date:11/6/2009)...WN, N.J., Nov. 6 Watson ...cialty pharmaceutical company, announced today tha...ive officer, will provide an overview and update o... Annual Healthcare Conference on Wednesday, Novemb..., This presentation will be webcast live and can ...
(Date:11/6/2009)...ON, S.C., Nov. 6 The ...n South Carolina and Georgia throughout the week o... uninsured and financially-struggling patients acc...ion medicines for free or nearly free. With the na... the Partnership for Prescription Assistance (PPA)...
(Date:11/6/2009)...Mass., Nov. 6 Boston Sci...that it has reached an agreement in principle with...roduct advisories issued by its Guidant subsidiary...ccurred prior to Boston Scientific,s 2006 acquisit...usly disclosed an investigation by the U.S. Attorn...
Breaking Medicine Technology:Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession 2Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession 3Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 3Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 4Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 5Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 6Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 7Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 8Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 9Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 10Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 11Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 12Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 13Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 14Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 15Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 16Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 17Screening for Cardiovascular Diseases Difficult but Necessary 60379 1Screening for Cardiovascular Diseases Difficult but Necessary 60379 2Skiing Not As Dangerous as Believed 60375 1Skiing Not As Dangerous as Believed 60375 2Skiing Not As Dangerous as Believed 60375 3Skiing Not As Dangerous as Believed 60375 4Emerging imaging modalities impact diagnosis of digestive disease 60371 1Emerging imaging modalities impact diagnosis of digestive disease 60371 2Emerging imaging modalities impact diagnosis of digestive disease 60371 3Emerging imaging modalities impact diagnosis of digestive disease 60371 4
... IDM Pharma, Inc.,(Nasdaq: IDMI ) today announce...e for Medicinal Products for Human Use (CHMP) and ...) on September 25th, following the,CHMP,s Septembe...eting,Authorization Application (MAA) for mifamurt...non-metastatic, resectable osteosarcoma, a rare,an...
...ective Effect of Quark,s New RNAi Product on,Dying...laucoma, FREMONT, Calif., Sept. 25 Quark Pharmac...company discovering and developing novel,RNA inter... QPI-1007 as the,Company,s first siRNA drug candid...ost of novel structures having freedom to operate ...
Other Medicine Technology:IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP) 2IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP) 3IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP) 4IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP) 5Quark Pharmaceuticals Announces First RNAi Drug Candidate Having a Novel, Proprietary Structure Covered by Quark Intellectual Property 2Quark Pharmaceuticals Announces First RNAi Drug Candidate Having a Novel, Proprietary Structure Covered by Quark Intellectual Property 3
(Date:11/8/2009)...swire/ -- USAction this evening hailed passage of ...will make health care more affordable for consumer...se access to health care for millions of Americans...FDR and Harry Truman would be proud," said USActio...ks among our country,s proudest achievements. Toda...
(Date:11/8/2009)...th Working Families vs. Insurance Companies ,,...- On the heels of an historic late night vote in t...ealth care reform bill, the Pennsylvania AFL-CIO r...entatives voted on HR 3962, the Affordable Health ...h passed Saturday evening by a vote of 220 to 215,...
(Date:11/7/2009)...ire/ -- The American Medical Association (AMA) tod...nship and Community Service to Manus C. Kraff, M.D...recognizes physicians who have gone above and beyo...tanding public service contribution to their local...ing the opening session of the 2009 Interim Meetin...
(Date:11/7/2009)...swire/ -- With the final House vote on healthcare ...the entire bill hostage to further their antiabort...r beyond the status quo restrictions on abortion t... In an outrageous amendment, which is expected to ...emocrats are demanding explicit and unequivocal ex...
(Date:11/7/2009)...ciety of America (PRSA) will bestow the distinguis...vice president of Brand Strategy, Communications a... at PRSA,s 2009 International Conference in San Di... Fellows is one of the profession,s highest indivi...ow PRSA, and 2009 chair of the College of Fellows....
Breaking Medicine News(10 mins):Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2Health News:AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 3
...w Year,s Resolution to focus on health by using th...program , , ORLANDO, Fla., Feb. 12 Over 2.6 mi... those currently unemployed also find themselves w...s in household budgets. Unfortunately, some people...
...OLA, Calif., Feb. 12 Fisher Vista, LLC, a marketi...enior care and human resource,industries today ann...company,for seven years, has been named president ...roup. Mr. Grossman will continue,to report to Mar...
...h enzastaurin, even tumors that did develop weren,...eb. 12 (HealthDay News) -- A drug called enzastaur...cancer in mice, and tumors that did develop were l...findings, coupled with the fact that the drug appe...
... and CEO, Scott Grisanti, Publishes Letter Outlini... Team , , BETHEL, Conn., Feb. 12 MedClean Techno...r of innovative technology and services for the on...ders. The letter, which is available on the Compa...
..., Feb. 12 After Phil Cohen, president of Clevelan...e interview last year, he signed on to do three mo...lly introduced those videos this week via PRN Fund...g,s three featured factoring educational videos ar...
...Dispels Myths Surrounding Essential Fat , , ST. L...rican Heart Association (AHA) concludes that omega... when part of a healthy eating plan. Omega-6s are ...ation leading to heart disease, the nation,s numbe...
Other Medicine News:Health News:During Tough Economic Times Remember Your Health - Save With Your AAA Membership on Necessities From Prescriptions to Eyeglasses 2Health News:During Tough Economic Times Remember Your Health - Save With Your AAA Membership on Necessities From Prescriptions to Eyeglasses 3Health News:Kevin Grossman Named President of HRmarketer.com 2Health News:Drug Inhibits Colon Cancer in Mice 2Health News:MedClean Technologies Inc. CEO Publishes Letter to Shareholders 2Health News:PRN Funding Introduces the PRN Funding YouTube Channel 2Health News:American Heart Association Finds Omega-6 Fatty Acids in Soybean Oil Are Heart-Healthy 2Health News:American Heart Association Finds Omega-6 Fatty Acids in Soybean Oil Are Heart-Healthy 3
Vitek 2
Vitek
IDS Rapid Yeast Plus
IDS Rapid SS/u
Medicine Products: